Skip to main content
. Author manuscript; available in PMC: 2016 Feb 26.
Published in final edited form as: Bone Marrow Transplant. 2014 Jun 2;49(8):1029–1035. doi: 10.1038/bmt.2014.116

Figure 1.

Figure 1

Survival after Relapse by Donor Type

UCB and related donor survival curves over the first year following relapse were similar (p=0.36); at one year, OS was 28% for UCB and 19% for related donor transplants. By three years after relapse, less than 10% in either group were alive.